Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CapnoSpot™ Pneumothorax Decompression Indicator

K-Number: K223625 · 2023-03-28

Decision Date2023-03-28
Product CodeGAA
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

CapnoSpot™ Pneumothorax Decompression Indicator is the device name listed in this FDA 510(k) record. The listed applicant is Pneumeric, Inc.. It received FDA 510(k) clearance on 2023-03-28 under 510(k) number K223625. The device is classified under product code GAA. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CapnoSpot™ Pneumothorax Decompression Indicator?

CapnoSpot™ Pneumothorax Decompression Indicator is a medical device that received FDA 510(k) clearance on 2023-03-28. The listed applicant is Pneumeric, Inc.. The 510(k) number is K223625.

When did CapnoSpot™ Pneumothorax Decompression Indicator receive FDA 510(k) clearance?

CapnoSpot™ Pneumothorax Decompression Indicator received FDA 510(k) clearance on 2023-03-28, under 510(k) number K223625.

Who is the listed applicant for CapnoSpot™ Pneumothorax Decompression Indicator?

The FDA 510(k) record lists Pneumeric, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator?

The FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator is GAA.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.